NDAORALCAPSULE
Approved
Mar 1967
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
3/8 — Basic
PONSTEL (mefenamic acid) by Molecular Devices is cyclooxygenase inhibitors [moa]. First approved in 1967.
Drug data last refreshed 3h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PONSTEL (mefenamic acid) is an oral nonsteroidal anti-inflammatory drug (NSAID) that works as a cyclooxygenase inhibitor to reduce pain and inflammation. It has been used since 1967 primarily for short-term pain relief, particularly dysmenorrhea and other acute pain conditions. The drug is administered orally in capsule form.
LOE Approaching
With LOE approaching and competitive pressure at 30%, the brand team is likely in optimization mode with reduced headcount and focus on retention.
Mechanism of Action
Cyclooxygenase Inhibitors
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults
Started Oct 2021
28 enrolled
Healthy Volunteers
Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects
Started Mar 2017
16 enrolled
Diabetes Mellitus
Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea
Started Jan 1998
337 enrolled
Dysmenorrhea
Career Relevance
Working on PONSTEL offers limited career advancement given its approaching LOE and minimal linked job openings (0 identified). This role is best suited for professionals seeking stability in a mature brand or those interested in generic transition strategies and cost-containment marketing.
Worked on PONSTEL at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.